Kazia Therapeutics reports early data from breast cancer trial patient
Go back to Kazia Therapeutics reports early data from breast cancer trial patient| (NASDAQ: KZIA) | Delayed: 13.41 -0.26 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.67 | 52 Week High | $ | |||
| Open | $13.67 | 52 Week Low | $ | |||
| Day High | $13.96 | P/E | N/A | |||
| Day Low | $13.06 | EPS | $ | |||
| Volume | 148,987 | |||||
